Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Co-Diagnostics Inc (CODX)

Co-Diagnostics Inc (CODX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,098
  • Shares Outstanding, K 31,930
  • Annual Sales, $ 6,810 K
  • Annual Income, $ -35,330 K
  • EBIT $ -39 M
  • EBITDA $ -37 M
  • 60-Month Beta -0.91
  • Price/Sales 4.39
  • Price/Cash Flow N/A
  • Price/Book 0.47
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.38
  • Most Recent Earnings $-0.32 on 11/07/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 189.48% ( -50.89%)
  • Historical Volatility 42.97%
  • IV Percentile 75%
  • IV Rank 30.88%
  • IV High 566.56% on 01/24/24
  • IV Low 20.99% on 12/19/23
  • Put/Call Vol Ratio 0.23
  • Today's Volume 158
  • Volume Avg (30-Day) 309
  • Put/Call OI Ratio 0.45
  • Today's Open Interest 13,748
  • Open Int (30-Day) 12,581

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.34
  • Number of Estimates 1
  • High Estimate -0.34
  • Low Estimate -0.34
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +32.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8500 +3.06%
on 12/02/24
1.2400 -29.35%
on 11/06/24
-0.3440 (-28.20%)
since 11/04/24
3-Month
0.8500 +3.06%
on 12/02/24
1.5800 -44.56%
on 09/05/24
-0.3740 (-29.92%)
since 09/04/24
52-Week
0.8500 +3.06%
on 12/02/24
2.2299 -60.72%
on 08/23/24
-0.4240 (-32.62%)
since 12/04/23

Most Recent Stories

More News
Alignment HealthCare Partners With Intermountain Health in Nevada

Alignment HealthCare, Inc.’s ALHC leading Medicare Advantage plan, Alignment Health Plan, is expanding its healthcare services in Nevada through a new agreement with Intermountain Health. Beginning Jan....

HQY : 103.00 (+1.59%)
ICCM : 0.8201 (+1.25%)
ALHC : 12.52 (-0.24%)
CODX : 0.8760 (-0.45%)
Co-Diagnostics, Inc. to Host Booth at Medlab Africa 2023 in Johannesburg, South Africa

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...

CODX : 0.8760 (-0.45%)
Co-Diagnostics, Inc. to Participate in the 2023 UHCA/UCAL Fall Convention & Expo on Sept 27-28

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...

CODX : 0.8760 (-0.45%)
Co-Diagnostics, Inc. to Participate in 6th ACTC Conference in Skiathos, Greece

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...

CODX : 0.8760 (-0.45%)
Co-Diagnostics, Inc. to Participate in Gilmartin Group Annual Emerging Growth Showcase on Sept 21

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...

CODX : 0.8760 (-0.45%)
Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 25th Annual Global Investment Conference on September 11-13, 2023

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...

CODX : 0.8760 (-0.45%)
The Five Biotech Stocks Every Investor Should Know About

Avalon GloboCare Corp., (NASDAQ: ALBT) a developer of innovative precision diagnostics and provider of clinical laboratory services just announced that the United States Patent and Trademark Office (USPTO)...

ALBT : 2.54 (+6.72%)
INSM : 75.36 (+4.05%)
VIR : 8.38 (-8.91%)
CODX : 0.8760 (-0.45%)
ANTX : 1.4900 (-0.67%)
A Potentially Revolutionary Tuberculosis Test Can Produce Results in 24 Hours

With a rising prevalence of chronic diseases, we’re starting to see higher demand for clinical lab services. That being said, it’s no surprise that, according to Market.Us, the global market for clinical...

INSM : 75.36 (+4.05%)
VIR : 8.38 (-8.91%)
CODX : 0.8760 (-0.45%)
ANTX : 1.4900 (-0.67%)
ALBT : 2.54 (+6.72%)
Co-Diagnostics, Inc. Appoints Chief Regulatory Affairs Officer

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dxâ„¢" or the "Company"), a molecular diagnostics company with a unique, patented platform for the...

CODX : 0.8760 (-0.45%)
Co-Diagnostics, Inc. to Present at 15th Next Generation Dx Summit in Washington, D.C.

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...

CODX : 0.8760 (-0.45%)

Business Summary

Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology...

See More

Key Turning Points

3rd Resistance Point 0.9408
2nd Resistance Point 0.9254
1st Resistance Point 0.9007
Last Price 0.8760
1st Support Level 0.8606
2nd Support Level 0.8452
3rd Support Level 0.8205

See More

52-Week High 2.2299
Fibonacci 61.8% 1.7028
Fibonacci 50% 1.5399
Fibonacci 38.2% 1.3771
Last Price 0.8760
52-Week Low 0.8500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar